Thomas Rohrer, MD
MOHS-Micrographic Surgery · Chestnut Hill, MANPI 1053384693
Payments from drug & device makers
Across 376 payments — averaging $113.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aclaris Therapeutics, Inc.$34K
- AbbVie$2K
- UCB, Inc.$770
- Sun Pharmaceutical Industries Inc.$747
- Lilly USA, LLC$614
- Amgen$554
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aclaris Therapeutics, Inc. | 8 | $33,697 |
| AbbVie(2 entities) | 64 | $1,825 |
| UCB, Inc. | 31 | $770 |
| Sun Pharmaceutical Industries Inc. | 34 | $747 |
| Lilly USA, LLC | 27 | $614 |
| Amgen | 21 | $554 |
| Johnson & Johnson | 24 | $534 |
| Novartis | 21 | $519 |
| Galderma Laboratories, L.p. | 21 | $489 |
| Incyte Corporation | 20 | $473 |
| LEO Pharma Inc. | 20 | $466 |
| E.r. Squibb & Sons, L.L.C. | 15 | $354 |
| Regeneron Healthcare Solutions, Inc. | 11 | $233 |
| Sanofi | 8 | $200 |
| Genentech USA, Inc. | 10 | $187 |
| Revance Therapeutics, Inc. | 3 | $153 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $113 |
| Pfizer | 5 | $113 |
| Boehringer Ingelheim | 4 | $110 |
| Organon | 3 | $89 |
| Bristol Myers Squibb | 4 | $87 |
| Arcutis Biotherapeutics, Inc. | 4 | $85 |
| Dermavant Sciences, Inc. | 4 | $76 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Mission Pharmacal Company | 2 | $46 |
| Mylan Pharmaceuticals Inc. | 2 | $33 |
| Botanix SB Inc | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Osiris Therapeutics Inc. | 1 | $13 |
How this compares
$42,696 in reported general payments places this provider in the 95th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in Chestnut Hill
- Chrysalyne SchmultsJamaica Plain$1.3M
- Suzanne OlbrichtBurlington$12K
- Sameer GuptaBoston$11K
- Jonathan WeissBoston$8K
- Helen RaynhamNatick$7K
- Omar BadriBeverly$7K
- Benjamin SolkyBoston$7K
- Carin LitaniWellesley Hills$5K
- Christine KannlerBeverly$4K
- Niels KrejciNorwood$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.